State Of Wisconsin Investment Board Durect Corp Transaction History

State Of Wisconsin Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$1.21 - $1.61 $108,900 - $144,900	-90,000 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$1.6 - $2.02 $307,520 - $388,244	-192,200 Reduced 68.11%	90,000 $147,000
Q4 2020 Feb 03, 2021	SELL	$1.65 - $2.43 $57,915 - $85,293	-35,100 Reduced 11.06%	282,200 $584,000
Q2 2020 Aug 12, 2020	BUY	$1.33 - $2.76 $422,009 - $875,747	317,300 New	317,300 $736,000
Q2 2019 Aug 14, 2019	SELL	$0.51 - $0.86 $109,140 - $184,040	-214,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$0.51 - $0.82 $24,990 - $40,180	49,000 Added 29.7%	214,000 $134,000
Q4 2018 Feb 11, 2019	BUY	$0.48 - $1.1 $32,640 - $74,800	68,000 Added 70.1%	165,000 $80,000
Q3 2017 Nov 01, 2017	BUY	$1.55 - $1.82 $150,350 - $176,540	97,000	97,000 $172,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $230M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.